Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B

Ceftriaxone, an FDA-approved third-generation cephalosporin antibiotic, has antimicrobial activity against both gram-positive and gram-negative organisms. Generally, ceftriaxone is used for a variety of infections such as community-acquired pneumonia, meningitis and gonorrhea. Its primary molecular...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Li, Xiang, Li, Haitao, Li, Shengqing, Zhu, Feng, Kim, Dong Joon, Xie, Hua, Li, Yan, Nadas, Janos, Oi, Naomi, Zykova, Tatyana A., Yu, Dong Hoon, Lee, Mee-Hyun, Kim, Myoung Ok, Wang, Lei, Ma, Weiya, Lubet, Ronald A., Bode, Ann M., Dong, Ziming, Dong, Zigang
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2012
Schlagworte:
Original Manuscript
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3510736/
https://ncbi.nlm.nih.gov/pubmed/22962305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgs283
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge